LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY Özgür Pekta¿; Marie Scully; Javier de la Rubia; Katerina Pavenski; Ara Metjian; Paul Knöbl; Flora Peyvandi; Spero Cataland; Paul Coppo; Johanna A. Kremer Hovinga; Jessica Minkue Mi Edou; Rui de Passos Sousa; Sriya Gunawardena; Julie Lin;

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA Flora Peyvandi; Spero Cataland; Marie Scully; Paul Coppo; Paul Knoebl; Johanna A. Kremer Hovinga; Ara Metjian; Javier de la Rubia; Katerina Pavenski; Jessica Minkue Mi Edou; Filip Callewaert; Hilde De Winter;